Gene · 38
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases. | Front Cell Dev Biol | 2021 | 34262910 | PubTator, text mining | PubMed |
| Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning. | iScience | 2021 | 34258555 | PubTator, text mining | PubMed |
| Energy metabolism in childhood neurodevelopmental disorders. | EBioMedicine | 2021 | 34256347 | PubTator, text mining | PubMed |
| Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects. | Front Aging Neurosci | 2021 | 34248607 | PubTator, text mining | PubMed |
| mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis. | Nat Commun | 2021 | 34244482 | PubTator, text mining | PubMed |
| Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | 34206705 | PubTator, text mining | PubMed |
| The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease. | Int J Mol Sci | 2021 | 34204153 | PubTator, text mining | PubMed |
| MicroRNA Sequences Modulated by Beta Cell Lipid Metabolism: Implications for Type 2 Diabetes Mellitus. | Biology (Basel) | 2021 | 34203703 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy. | Int J Mol Sci | 2021 | 34200820 | PubTator, text mining | PubMed |
| Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy. | Onco Targets Ther | 2021 | 34188488 | PubTator, text mining | PubMed |
| Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development. | Drug Des Devel Ther | 2021 | 34188450 | PubTator, text mining | PubMed |
| Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. | Environ Int | 2021 | 34186270 | PubTator, text mining | PubMed |
| ATP Drives Efficient Terpene Biosynthesis in Marine Thraustochytrids. | mBio | 2021 | 34182781 | PubTator, text mining | PubMed |
| Molecular dynamics simulation of Fe-NO2 At-alpha mangostin as radiopharmaceutical model for detection of fatty acid synthase in cancer. | J Adv Pharm Technol Res | 2021 | 34159140 | PubTator, text mining | PubMed |
| Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives. | Theranostics | 2021 | 34158845 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids. | J Colloid Interface Sci | 2021 | 34157514 | PubTator, text mining | PubMed |
| ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease. | J Genet Eng Biotechnol | 2021 | 34156559 | PubTator, text mining | PubMed |
| Anti-Tumor Effects of BDH1 in Acute Myeloid Leukemia. | Front Oncol | 2021 | 34150668 | PubTator, text mining | PubMed |
| Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients. | Front Immunol | 2021 | 34135895 | PubTator, text mining | PubMed |
| Proteomic analysis of chicken bone marrow-derived dendritic cells in response to an inactivated IBV + NDV poultry vaccine. | Sci Rep | 2021 | 34135356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/38/papers?page=48